Protara Therapeutics, Inc.
TARA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001359931
In the last 90 days, Protara Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 119 institutions reported holding it in 13F filings for Q2 2026, worth $176.0M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Protara Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- 0 vs. Q3 2022
- Shares held
- 5.48M
- −180.2K (−3.2%) vs. Q3 2022
- Total value
- $14.7M
- −$2.04M (−12.2%) vs. Q3 2022
- New holders
- 3
- 6 more added
- Sold out
- 3
- 10 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TARA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 119 | $176.0M |
| Q1 2026 | 114 | $237.4M |
| Q4 2025 | 105 | $212.3M |
| Q3 2025 | 81 | $114.0M |
| Q2 2025 | 76 | $90.1M |
| Q1 2025 | 59 | $123.8M |
| Q4 2024 | 60 | $156.6M |
| Q3 2024 | 35 | $19.1M |
| Q2 2024 | 38 | $22.2M |
| Q1 2024 | 34 | $18.3M |
| Q4 2023 | 30 | $8.17M |
| Q3 2023 | 31 | $8.55M |
| Q2 2023 | 29 | $12.3M |
| Q1 2023 | 29 | $16.9M |
| Q4 2022 | 30 | $14.7M |
| Q3 2022 | 31 | $16.7M |
| Q2 2022 | 33 | $18.4M |
| Q1 2022 | 35 | $33.2M |
| Q4 2021 | 38 | $46.5M |
| Q3 2021 | 36 | $43.7M |
| Q2 2021 | 40 | $69.3M |
| Q1 2021 | 50 | $134.0M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Protara Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Opaleye Management Inc. | 2,692,594 | $7.22M | 2.51% | −15,473−0.6% | Reduced |
| OrbiMed Advisors LLC | 830,641 | $2.23M | 0.04% | 00.0% | Unchanged |
| Vanguard Group Inc | 427,612 | $1.15M | 0.00% | +224+0.1% | Added |
| Perceptive Advisors LLC | 290,051 | $777.3K | 0.02% | 00.0% | Unchanged |
| Boxer Capital, LLC | 209,227 | $560.7K | 0.03% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 199,671 | $535.1K | 0.00% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 188,664 | $505.6K | 0.21% | 00.0% | Unchanged |
| Privium Fund Management (UK) Ltd | 119,730 | $320.9K | 0.24% | +84,730+242.1% | Added |
| Geode Capital Management, LLC | 83,420 | $223.0K | 0.00% | −224−0.3% | Reduced |
| Renaissance Technologies LLC | 67,000 | $180.0K | 0.00% | −12,200−15.4% | Reduced |
| Bridgeway Capital Management, LLC | 64,000 | $171.5K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 47,218 | $126.5K | 0.00% | −5,200−9.9% | Reduced |
| Two Sigma Investments, LP | 46,147 | $123.7K | 0.00% | −4,901−9.6% | Reduced |
| BlackRock Inc. | 36,360 | $97.4K | 0.00% | +859+2.4% | Added |
| State Street Corp | 30,900 | $82.8K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 29,626 | $79.0K | 0.00% | −20,581−41.0% | Reduced |
| Northern Trust Corp | 20,019 | $53.7K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 18,864 | $50.6K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 17,907 | $48.0K | 0.00% | 00.0% | Unchanged |
| Assenagon Asset Management S.A. | 17,336 | $46.0K | 0.00% | −41,053−70.3% | Reduced |
| Dimensional Fund Advisors LP | 16,834 | $45.0K | 0.00% | +1,052+6.7% | Added |
| Citadel Advisors LLC | 14,848 | $39.8K | 0.00% | −155,674−91.3% | Reduced |
| Acadian Asset Management LLC | 6,314 | $16.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 2,300 | $6.16K | 0.00% | +2,061+862.3% | Added |
| Wells Fargo & Company | 559 | $1.50K | 0.00% | +1+0.2% | Added |
| Federated Hermes, Inc. | 124 | $332 | 0.00% | −122−49.6% | Reduced |
| Advisor Group Holdings, Inc. | 100 | $268 | 0.00% | +100 | New |
| Morgan Stanley | 25 | $67 | 0.00% | −219−89.8% | Reduced |
| Bank of America Corp | 22 | $58 | 0.00% | +22 | New |
| Tower Research Capital LLC (TRC) | 133 | $0 | 0.00% | +133 | New |
| Virtu Financial LLC | 0 | $0 | 0.00% | −12,465−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Financial Advocates Investment Management | 0 | $0 | 0.00% | −1,161−100.0% | Sold out |
| American Portfolios Advisors | – | – | – | – | Not filed |